A LOOK INTO BIOPRINTING

Imagine working in a little lab, playing & tinkering with UV technology during long evenings and weekends and then one day, you unintentionally invent one of the most innovative techniques to ever be introduced to the field of medicine. Charles Hull, an American engineer, launched the industry of bioprinting through his invention of stereolithography. Hull was developing lamps for UV-curable resins when he first came up with his idea for 3D printing. His method uses UV light to cure and bond a photopolymer resin which is built up layer by layer. Today, his idea behind 3D printing has been used to propel the creation of artificial organs and has advanced the field of regenerative medicine.
There is a global shortage of organs available for lifesaving transplants. Specifically, there is a shortage of kidneys, liver, lungs and other essential organs on a global basis; people are having to delay transplants due to their status on the transplant waiting lists.The lack of transplant tissues is estimated to be the leading cause of death in America. Around 900,000 deaths a year, or around one-third of all deaths in the US, could be prevented or delayed by organ or engineered tissue transplants. The demand, simply, is endless but bioprinting could help to resolve this issue and help patients worldwide.